|
|
 | |  | | | S |  | |  | | Sadones N.
MICROWAVE-ASSISTED ON-SPOT DERIVATIZATION FOR THE GC-MS BASED DETERMINATION OF POLAR LOW MOLECULAR WEIGHT MOLECULES -AMONGST WHICH GHB AND BHB- IN DRIED BLOOD SPOTS |
| |  | |  |
| | | | Salomone A.
INNOVATIVE CHEMOMETRIC APPROACHES AS POWERFUL TOOLS IN THE ATHLETE BIOLOGICAL PASSPORT |
| | | | |
| | | | Schaefer N.
PHARMACOKINETIC MODELLING OF JWH-210, RCS-4, AND THC IN PIG SERUM AFTER INTRAVENOUS ADMINISTRATION |
| | | | |
| | | | Schallmach E.
DRIVING UNDER THE INFLUENCE OF ALCOHOLAMONG CAR DRIVERS IN ISRAEL |
| | | | |
| | | | Schallmach E.
TRENDS AND CHANGES IN THE SYNTHETIC CANNABINOID DRUGS MARKET IN ISRAEL BETWEEN 2010-2014 |
| | | | |
| | | | Schroeck A.
DEVELOPMENT OF A STANDARDISED TEST FOR THE ACTIVITY OF THE ENZYME PHOSPHOLIPASE D (PLD), RESPONSIBLE FOR BIOSYNTHESIS OF THE ALCOHOL BIOMARKER PHOSPHATIDYLETHANOL (PETH) |
| | | | |
| | | | Scott T.
SUPPORTED LIQUID EXTRACTION (SLE) FOR THE ANALYSIS OF METHYLAMPHETAMINE, METHYLENEDIOXYMETHYLAMPHETAMINE AND DELTA-9-TETRAHYDROCANNABINOL IN ORAL FLUID AND BLOOD |
| | | | |
| | | | Simões S.
UPLC-MS/MS METHOD FOR THE SIMULTANEOUS DETERMINATION OF 35 SUBSTANCES INCLUDING MEDICINES AND DRUGS OF ABUSE ON DRIED BLOOD SPOTS APPLIED IN FORENSIC TOXICOLOGY |
| | | | |
| | | | Sinagawa D. M.
USE OF PSYCHOACTIVE SUBSTANCES AMONG TRUCK DRIVERS IN THE HIGHWAYS OF THE STATE OF SAO PAULO, BRAZIL |
| | | | |
| | | | Skopp G.
FORMATION AND INHIBITION OF ETHYL GLUCURONIDE AND ETHYL SULFATE |
| | | | |
| | | | Skov L.
QUETIAPINE IN BRAIN TISSUE |
| | | | |
| | | | Smink B.
GHB IN SUSPECTED IMPAIRED DRIVERS IN THE NETHERLANDS AND A COMPARISON WITH POSTMORTEM CASES. |
| | | | |
| | | | Snozek C.
DRUG SCREENING AND ILLICIT DRUG USE IN A TWO-SITE SOLID ORGAN TRANSPLANT PRACTICE |
| | | | |
| | | | Soichot M.
LIFE-THREATENING AMLODIPINE POISONING: THE RESPECTIVE ROLE OF VENO-ARTERIAL ECMO, LIPID RESCUE AND MARS© BASED ON THE ANALYSIS OF PLASMA AMLODIPINE PHARMACOKINETICS |
| | | | |
| | | | Staeheli S. N.
TIME-DEPENDENT POSTMORTEM REDISTRIBUTION OF CENTRALLY ACTING SUBSTANCES |
| | | | |
| | | | Steuer A. E. , Boxler M.
INHIBITION POTENTIAL OF MDMA AND ITS RELEVANT METABOLITES ON THE IN VITRO DEAMINATION OF SEROTONIN AND DOPAMINE |
| | | | |
| | | | Steuer A. E.
CYP2D6 GENOTYPE-DEPENDING CHIRAL PHARMACOKINETICS AND PHASE I AND II METABOLISM OF MDMA AFTER CO-ADMINISTRATION OF BUPROPION IN A CONTROLLED STUDY IN HUMANS |
| | | | |
| | | | Steven B. Karch
"The Story of Hurricane Katrina" |
| | | | |
| | | | Stoykova S.
CONFIRMATORY AND COMPARATIVE DRUG ANALYSIS OF ORAL FLUID / BLOOD SPECIMENS FROM DRIVERS |
| | | | |
| | | | Strano Rossi S.
METHODS DEVELOPMENT FOR THE ASSESSMENT OF NPS USE BY ANALYSIS OF DIFFERENT BIOLOGICAL SAMPLES: HAIR, BLOOD AND URINE |
| | | | |
| | | | Swortwood M.
FIRST METABOLIC PROFILE OF PV8, A NOVEL SYNTHETIC CATHINONE, BY HIGHRESOLUTION MASS SPECTROMETRY (HRMS) |
| | | | |
|
| |  | |  |
|
|